Quality of life in sarcopenia measured with the SarQoL questionnaire: A meta-analysis of individual patient data.

Age-related sarcopenia, resulting from a gradual loss in skeletal muscle mass and strength, is pivotal to the increased prevalence of functional limitation among the older adult community. The purpose of this meta-analysis of individual patient data is to investigate the difference in health-related quality of life between sarcopenic individuals and those without the condition using the Sarcopenia Quality of Life (SarQoL) questionnaire. A protocol was published on PROSPERO. Multiple databases and the grey literature were searched until March 2023 for studies reporting quality of life assessed with the SarQoL for patients with and without sarcopenia. Two researchers conducted the systematic review independently. A two-stage meta-analysis was performed. First, crude (mean difference) and adjusted (beta coefficient) effect sizes were calculated within each database; then, a random effect meta-analysis was applied to pool them. Heterogeneity was measured using the Q-test and I2 value. Subgroup analyses were performed to investigate the source of potential heterogeneity. The strength of evidence of this association was assessed using GRADE. From the 413 studies identified, 32 were eventually included, of which 10 were unpublished data studies. Sarcopenic participants displayed significantly reduced health-related quality of life compared with non-sarcopenic individuals (mean difference = -12.32; 95 % CI = [-15.27; -9.37]). The model revealed significant heterogeneity. Subgroup analyses revealed a substantial impact of regions, clinical settings, and diagnostic criteria on the difference in health-related quality of life between sarcopenic and non-sarcopenic individuals. The level of evidence was moderate. This meta-analysis of individual patient data suggested that sarcopenia is associated with lower health-related quality of life measured with SarQoL.

Nutritional status and quality of life are associated with risk of sarcopenia in nursing home residents: a cross-sectional study.

Sarcopenia, which is characterized by an age-related decline in skeletal muscle mass, strength, and function, is an important geriatric syndrome that is closely related to the nutritional status and quality of life (QoL) of older adults. The aim of this study was to compare the nutritional status and QoL of nursing home residents according to sarcopenia. We hypothesized that a daily protein intake <1.2 g/kg is associated with a higher risk of sarcopenia. This study was performed with 172 older adults living a nursing home. Sarcopenia was defined according to the consensus of the European Working Group on Sarcopenia in Older People. The nutritional status was evaluated using the Mini Nutritional Assessment-Short Form, 24-hour dietary recall. Frailty was evaluated using the Fatigue, Resistance, Ambulation, Illnesses, and Loss of weight scale and health-related QoL was evaluated by the European Quality of Life-5 Dimensions scale. In addition to the anthropometric measurements associated with sarcopenia, QoL was also lower in sarcopenic individuals. The risk of malnutrition and frailty status were more prevalent among the sarcopenic individuals. In the multivariate logistic regression analysis, a higher QoL score was related with a low risk for sarcopenia, whereas the risk of malnutrition, a daily protein intake that was <1.2 g/kg/d, and being >80 years of age remained predictive of sarcopenia after adjustment. Sarcopenic nursing home residents have a great risk of malnutrition and lower QoL. This study showed that QoL, the risk of malnutrition, and daily protein intake are important factors as potential target areas for the management of sarcopenia in nursing home residents.